title: Bone-Targeted Therapy in Prostate Cancer in 2017: Lost Opportunities, Confusion, and Controversy.
authors.affiliation: Fred Saad, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
authors.forename: Fred
authors.initials: F
authors.lastname: Saad
mesh_terms: D000068579:Celecoxib; D004164:Diphosphonates; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D000077211:Zoledronic Acid; D000068579:Celecoxib